"That depends," Kuranosuke says rather vaguely. Like with any investment, there will be a lot of moving parts. Pharma just happens to be one of the riskier ones.

He has a great eye for how certain products or companies will perform, but medicine is notoriously unpredictable and time consuming.

"You'll need to buy a lot, and be prepared for a fair number of set-backs."